Physical, mechanical and pharmacological properties of coloured bone cement with and without antibiotics

Journal of Bone and Joint Surgery - Series B

Volumn 93 B, Issue 11, 2011, Pages 1529-1536

  Galasso, O ^a   Mariconda, M ^a,b   Calonego, G ^a,c   Gasparini, G ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Tecres SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BONE CEMENT; GENTAMICIN; METHYLENE BLUE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS SUBTILIS; BONE BOWING; BONE STRENGTH; COMPRESSION; ELUTION; KINETICS; NONHUMAN; PRIORITY JOURNAL; YOUNG MODULUS;

ANTI-BACTERIAL AGENTS; BONE CEMENTS; CHEMISTRY, PHYSICAL; COLORING AGENTS; COMPRESSIVE STRENGTH; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; ELASTIC MODULUS; GENTAMICINS; HUMANS; MATERIALS TESTING; METHYLENE BLUE; TENSILE STRENGTH; VANCOMYCIN;

EID: 81155144663     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.93B11.26955     Document Type: Article

References (30)

1. Engesaeter LB, Espehaug B, Lie SA, Furnes O, Havelin LI. Does cement increase the risk of infection in primary total hip arthroplasty: revision rates in 56,275 cemented and uncemented primary THAs followed for 0-16 years in the Norwegian Arthroplasty Register. Acta Orthop 2006;77:351-358. (Pubitemid 43977388)
2. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Antibiotic prophylaxis in total hip arthroplasty: review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg [Br] 1997;79-B:590-595. (Pubitemid 127469741)
3. Malchau H, Herberts P, Ahnfelt L. Prognosis of total hip replacement in Sweden: follow up of 92,675 operations performed 1978-1990. Acta Orthop Scand 1993;64:497-506. (Pubitemid 23329852)
4. Willis-Owen CA, Konyves, A Martin DK. Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5277 cases. J Bone Joint Surg [Br[ 2010;92-B:1128-33.
5. Dunbar MJ. Antibiotic bone cements: their use in routine primary total joint arthroplasty is justified. Orthopedics 2009;32:660.
6. McNie CM, Barton DC, Fisher J, Stone MH. Modeling of damage to articulating surfaces by third body particles in total joint replacements. J Mater Sci Mater Med 2000;11:569-578.
7. Bargar WL, Martin RB, de Jesus R, Madison MT. The addition of tobramycin to contrast bone cement: effect on flexural strength. J Arthroplasty 1986;1:165-168. (Pubitemid 17197230)
8. Bargar WL, Heiple KG, Weber S, et al. Contrast bone cement. J Orthop Res 1983;1:92-100. (Pubitemid 14172111)
9. Graves RM, Sands KC. Making a cost-effective contrast bone cement with or without antibiotics, using aqueous methylene blue for easy cement removal in revision and primary total joint arthroplasty. Orthopedics 2007;30:825-827. (Pubitemid 350032729)
10. Davies JP, Harris WH. The effect of the addition of methylene blue on the fatigue strength of Simplex P bone-cement. J Appl Biomater 1992;3:81-85.
11. Lewis G. Effect of methylene blue on the fracture toughness of acrylic bone cement. Biomaterials 1994;15:1024-1028. (Pubitemid 24311503)
12. No authors listed. International Organization for Standardization. Implants for surgery- acrylic resin cements, 2010 (ISO 5833:2002). http://www.iso.org/iso/iso-catalogue/catalogue-tc/catalogue-detail.htm?csnumber= 30980 (date last accessed 12 July 2011).
13. Bassi C, Pederzoli P, Vesentini S, et al. Behavior of antibiotics during human necrotizing pancreatitis. Antimicrob Agents Chemother 1994;38:830-836. (Pubitemid 24114026)
14. Wilker MA, Cockerill FR, Bush K, et al. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically; approved standard. Eighth ed. 2009 (M07-A8). http://www.clsi.org/source/orders/free/m07-a8.pdf (date last accessed 12 July 2011).
15. No authors listed. American Society for Testing and Materials. Standard specification for acrylic bone cements. 1976 (F451-76). http://www.astm.org/ Standards/F451.htm (date last accessed 12 July 2011).
16. Saha S, Pal S. Mechanical properties of bone cement: a review. J Biomed Mater Res 1984;18:435-462. (Pubitemid 14101925)
17. Liacouras PC, Owen JR, Jiranek WA, Wayne JS. Effect of pigmentation on the mechanical and polymerization characteristics of bone cement. J Arthroplasty 2006;21:606-611. (Pubitemid 43866396)
18. Horobin RW, Kiernan JA. Conn's biological stains: a handbook of dyes, stains and fluorochromes for use in biology and medicine. Tenth ed. Oxford: Bios Scientific Publishers Ltd, 2002:177-8.
19. Anagnostakos K, Kelm J. Enhancement of antibiotic elution from acrylic bone cement. J Biomed Mater Res B Appl Biomater 2009;90:467-475.
20. Di Maio FR. The science of bone cement: a historical review. Orthopedics 2002;25:1399-1407. (Pubitemid 36040756)
21. Klekamp J, Dawson JM, Haas DW, DeBoer D, Christie M. The use of vancomycin and tobramycin in acrylic bone cement: biochemical effects and elution kinetics for use in joint arthroplasties. J Arthroplasty 1999;14:339-346. (Pubitemid 29172251)
22. Seligson D, Popham GJ, Voos K, Henry SL, Faghri M. Antibiotic-leaching from polymethylmethacrylate beads. J Bone Joint Surg [Am] 1993;75-A:714-720. (Pubitemid 23199105)
23. Bertazzoni Minelli E, Caveiari C, Benini A. Release of antibiotics from polymethylmethacrylate cement. J Chemother 2002;14:492-500. (Pubitemid 35346994)
24. Bridgens J, Davies S, Tilley L, Norman P, Stockley I. Orthopaedic bone cement: do we know what we are using? J Bone Joint Surg [Br] 2008;90-B:643-647. (Pubitemid 351685012)
25. Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg [Am] 2006;88-A:2487-2500. (Pubitemid 44713839)
26. Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone cement. J Arthroplasty 1996;11:939-944.
27. Lautenschlager EP, Jacobs JJ, Marshall GW, Meyer Jr PR. Mechanical properties of bone cements containing large doses of antibiotic powders. J Biomed Mater Res 1976;10:929-938.
28. Postak PD, Greenwald AS. Assuring cement fixation: all mixing systems are not the same. Pro Am Acad Orthop Surg 2003;4:656.
29. Nelson CL, Griffin FM, Harrison BH, Cooper RE. In vitro elution characteristics of commercially and noncommercially prepared antibiotic PMMA beads. Clin Orthop 1992;284:303-309.
30. Neut D, van de Belt H, van Horn JR, van der Mei HC, Busscher HJ. Residual gentamicin-release from antibiotic-loaded polymethylmethacrylate beads after 5 years of implantation. Biomaterials 2003;24:1829-1831. (Pubitemid 36184738)